Lisa Schweizer retweeted
Andreas Mund discusses his recent Cancer Discovery paper, AI-powered Deep Visual Proteomics reveals critical molecular transitions in pancreatic cancer precursors. Check it out: doi.org/10.1158/2159-8290.CD…
Lisa Schweizer retweeted
Now online: AI-powered Deep Visual Proteomics reveals critical molecular transitions in
pancreatic cancer precursors doi.org/10.1158/2159-8290.CD…
Lisa Schweizer retweeted
Out now in @CD_AACR, timed with my #AACR26 talk.
Deep Visual Proteomics across the full PanIN → PDAC progression. 5,800+ proteins per region from 50–100 cells, 9,181 across the dataset. Normal ducts next to cancer aren't normal. Mass spec reads KRAS hotspot mutations directly off the protein.
bit.ly/3OxHiSQ
Lisa Schweizer retweeted
New preprint reveals why IDO1 inhibitor trials failed! Led by Peter Murray @MPI_biochem, our collaboration discovered IDO1 actually kills ovarian cancer cells via GCN2/ISR pathway - not protecting them. Spatial proteomics uncovers unexpected biology.
biorxiv.org/content/10.1101/…
Lisa Schweizer retweeted
Spatial proteo-transcriptomic profiling reveals the molecular landscape of borderline ovarian tumors and their invasive progression dlvr.it/TMSCHQ
Lisa Schweizer retweeted
New study from @rweichselbaum and team show high-dose radiation triggers amphiregulin, a protein that weakens immunity and fuels distant cancer spread—pointing to new strategies for blocking its effects. @SeanPitroda @AndrasPiffko @UChicagoRadonc @Nature
ow.ly/HgVU50Wn6ZY
Lisa Schweizer retweeted
Very excited to share our preprint on #AI directed Deep Visual Proteomics (DVP) on #PancreaticCancer precursor lesions (PanINs), in collaboration with @OmicVision @MundAndreas
Thousands of proteins from as few as ~100 precisely microdissected cells in archival samples!
Lisa Schweizer retweeted
New @biorxivpreprint ! With Dr. Maitra @Aiims1742 (@MDAndersonNews) & Nebraska Rapid Autopsy Program, we used AI-powered Deep Visual Proteomics to map early molecular changes in pancreatic cancer precursor lesions.
Read: bit.ly/4nAqPK8
#SpatialMedicine #PDAC
Lisa Schweizer retweeted
📢 New in Cancer Cell: Radiotherapy is essential for local control—but can it unintentionally accelerate growth of distant metastases? We examine how RT-induced EGFR signaling and immune modulation may fuel metastatic progression.
🧠🧬🔬
Read: doi.org/10.1016/j.ccell.2025…
Lisa Schweizer retweeted
Online Now: Spatial proteo-transcriptomic profiling reveals the molecular landscape of borderline ovarian tumors and their invasive progression dlvr.it/TLbW6y
Lisa Schweizer retweeted
Proud to share our latest work now in @Cancer_Cell. In collaboration with @MPI_Biochem, we map the progression from borderline ovarian tumors to low-grade serous ovarian cancer & propose a promising new therapeutic strategy.
sciencedirect.com/science/ar…
#LGSC #SBT
Lisa Schweizer retweeted
An interdisciplinary study @labs_mann & @uchicago_obgyn uncovers how benign borderline ovarian tumors develop into invasive low-grade serous carcinoma, opening a new avenue for targeted therapy.
❕Publication: cell.com/cancer-cell/fulltex…
❕Press Release: biochem.mpg.de/when-tumors-t…
Lisa Schweizer retweeted
A new publication in @Cancer_Cell uncovers how borderline ovarian tumors evolve into low-grade serous ovarian cancer & identifies a promising new treatment strategy.
Read: bit.ly/4luXCP8
@UCCancerCenter @LisaCSchweizer @hkenny228 @ErnstLengyel @labs_mann @MPI_Biochem
Lisa Schweizer retweeted
Happy to share our preprint in collaboration with the Lundberg Lab revealing spatial heterogeneity in human pancreatic islets with multiplexed Deep Visual Proteomics. Grateful for the fantastic team and collaboration!
Excited to share our preprint on multiplexed DVP! mxDVP extends CODEX to DVP family, revealing spatial heterogeneity in human pancreatic islets with 12 endocrine sub-types including rare polyhormonal cells. Fantastic team effort @Prof_Lundberg #LundbergLab biorxiv.org/content/10.1101/…
Lisa Schweizer retweeted
Check out our @Nature review with Tiannan Guo @guomics and Judith Steen @ionicwoman on recent paradigm shifts in MS-based proteomics - where the field stands and where its headed. #Proteomics #AI
nature.com/articles/s41586-0…
Lisa Schweizer retweeted
After 4 fantastic years of research, with @caina89 & @heinig_matthias, I’m thrilled to share the first tissue specific map of apparent mtDNA heteroplasmy in humans and their relationships with donor age and mtDNA gene expression across 49 human tissues!👇
biorxiv.org/content/10.1101/…
Lisa Schweizer retweeted
Exciting news - Spatial Proteomics is @naturemethods’ 2024 Method of the Year! Our commentary highlights how Deep Visual Proteomics (DVP) unites imaging, data science & high-res proteomics at single-cell resolution, fueling predictive tissue models and personalized medicine. Stay tuned! #DVP #SpatialProteomics #SpatialMedicine @UCPH_CPR @MPI_Biochem @novonordiskfond
The wait is over!! We are thrilled to announce that we have chosen Spatial Proteomics as 2024’s Method of the Year! 🥳
For more on Spatial Proteomics and a road map to this special issue, please see this month’s Editorial or read on in this thread.
nature.com/articles/s41592-0…
Lisa Schweizer retweeted
The wait is over!! We are thrilled to announce that we have chosen Spatial Proteomics as 2024’s Method of the Year! 🥳
For more on Spatial Proteomics and a road map to this special issue, please see this month’s Editorial or read on in this thread.
nature.com/articles/s41592-0…
Lisa Schweizer retweeted
Spatial Omics enthusiasts!! Spatial Proteomics is the Method of the Year 2024
🤩🤩🤩
nature.com/nmeth/volumes/21/…
Lisa Schweizer retweeted
Four years after the 2020 Method of the Year (“spatially resolved transcriptomics”), @naturemethods has now nominated “spatial proteomics” as the 2024 Method of the Year.
H/T @RongFan8 (spatial guru!)
































